Owen Stell, MD
Critical Care Medicine · Baton Rouge, LANPI 1508248790
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,335, 2.1 times the $634 reported in 2019.
Across 136 payments — averaging $25.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$613
- Actelion Pharmaceuticals US, Inc.$344
- AstraZeneca$234
- Merck$199
- Grifols USA, LLC$182
- Johnson & Johnson$174
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,465100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 10 | $613 |
| Actelion Pharmaceuticals US, Inc. | 27 | $344 |
| AstraZeneca | 12 | $234 |
| Merck | 12 | $199 |
| Grifols USA, LLC | 7 | $182 |
| Johnson & Johnson | 10 | $174 |
| Edwards Lifesciences | 1 | $168 |
| Abbott | 3 | $153 |
| Pfizer | 8 | $152 |
| Boston Scientific | 1 | $142 |
| Getinge USA Sales, LLC | 2 | $134 |
| Boehringer Ingelheim | 9 | $126 |
| Viatris Specialty LLC | 5 | $120 |
| Baxter Healthcare | 4 | $89 |
| Livanova USA, Inc. | 1 | $83 |
| Agiliti Health, Inc. | 1 | $72 |
| Nuwellis, Inc. | 1 | $50 |
| AbbVie | 2 | $40 |
| Shionogi Inc | 2 | $37 |
| UCB, Inc. | 2 | $37 |
| United Therapeutics Corporation | 1 | $32 |
| BD | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| GSK | 2 | $25 |
| Verona Pharma, Inc. | 1 | $25 |
| Coaptech, Inc. | 1 | $25 |
| Insmed, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $24 |
| Cook Medical LLC | 1 | $23 |
| La Jolla Pharmaceutical Company | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Inogen, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,465 in reported general payments places this provider in the 70th percentile of 72 critical care medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Baton Rouge
- Abdulla Majid-MoosaBaton Rouge$202K
- Ahmad SharayahBaton Rouge$12K
- Ronald FieldsBaton Rouge$11K
- Merissa BraudBaton Rouge$8K
- James VermaelenBaton Rouge$8K
- Mostafa AboubakrBaton Rouge$6K
- James FordBaton Rouge$6K
- Vincent ValentineBaton Rouge$6K
- Daniel ReesBaton Rouge$4K
- Dena LandryBaton Rouge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.